These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28039147)

  • 1. Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors.
    Xue A; Gao X; Fang Y; Shu P; Ling J; Shen K; Sun Y; Qin J; Qin X; Hou Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):179-185. PubMed ID: 28039147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
    Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
    Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of preoperative neutrophil-lymphocyte ratio for surgically resected gastrointestinal stromal tumors.
    Yang J; Gu Y; Huang X; Xu J; Zhang Y; Yang X; Tian H; Zhan W
    Medicine (Baltimore); 2019 Apr; 98(16):e15319. PubMed ID: 31008985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
    Sun J; Ning H; Sun J; Qu X
    Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
    Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
    Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-lymphocyte ratio: could it be used in the clinic as prognostic marker for gastrointestinal stromal tumor?
    Atila K; Arslan NC; Derici S; Canda AE; Sagol O; Oztop I; Bora S
    Hepatogastroenterology; 2014 Sep; 61(134):1649-53. PubMed ID: 25436357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors.
    Feng F; Tian Y; Liu S; Zheng G; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
    Medicine (Baltimore); 2016 Apr; 95(14):e3248. PubMed ID: 27057867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.
    Rutkowski P; Teterycz P; Klimczak A; Bylina E; Szamotulska K; Lugowska I
    Tumori; 2018 Dec; 104(6):415-422. PubMed ID: 29714669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive ability of prognostic nutritional index in surgically resected gastrointestinal stromal tumors: a propensity score matching analysis.
    Shi WK; Zhang XH; Zhang J; Yu M; Yuan YJ; Xiong W; Zhang CH; He YL; Wei ZW
    Jpn J Clin Oncol; 2019 Sep; 49(9):823-831. PubMed ID: 31162583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.
    Mano Y; Shirabe K; Yamashita Y; Harimoto N; Tsujita E; Takeishi K; Aishima S; Ikegami T; Yoshizumi T; Yamanaka T; Maehara Y
    Ann Surg; 2013 Aug; 258(2):301-5. PubMed ID: 23774313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
    Cai HX; Li XQ; Wang SF
    World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
    Stotz M; Liegl-Atzwanger B; Posch F; Mrsic E; Thalhammer M; Stojakovic T; Bezan A; Pichler M; Gerger A; Szkandera J
    PLoS One; 2016; 11(7):e0159448. PubMed ID: 27454486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis.
    Tsujita E; Ikeda Y; Kinjo N; Yamashita YI; Hisano T; Furukawa M; Taguchi KI; Morita M; Toh Y; Okamura T
    Am Surg; 2017 Jun; 83(6):610-616. PubMed ID: 28637563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of neutrophil to lymphocyte ratio in patients with gastrointestinal stromal tumors: A meta-analysis.
    Luo XF; Zhou LH
    Clin Chim Acta; 2018 Feb; 477():7-12. PubMed ID: 29175648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.
    Yang HJ; Guo Z; Yang YT; Jiang JH; Qi YP; Li JJ; Li LQ; Xiang BD
    World J Gastroenterol; 2016 Jun; 22(21):5088-95. PubMed ID: 27275101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and prognosis of primary gastrointestinal stromal tumor patients under 35 years of age: A 10-year retrospective study.
    Zhang P; Deng R; Liu K; Shuai XM; Bai J; Chang WL; Gao JB; Cai KL; Wang GB; Tao KX
    J Surg Oncol; 2016 Dec; 114(8):977-981. PubMed ID: 27664034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
    Yu L; Lv CY; Yuan AH; Chen W; Wu AW
    World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
    Formica V; Morelli C; Ferroni P; Nardecchia A; Tesauro M; Pellicori S; Cereda V; Russo A; Riondino S; Guadagni F; Roselli M
    Cancer Biomark; 2016 Sep; 17(3):335-345. PubMed ID: 27434293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.